GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, announces its plans to acquire Fabric Genomics, a pioneer in AI-powered genomic interpretation. The transaction enables GeneDx’s leadership in the next phase of genomic medicine: decentralized testing with centralized intelligence. As DNA sequencing continues to become more accessible, decoupling interpretation services from the physical reliance on a wet lab allows for more flexibility to seamlessly integrate with provider and health system workflows, both in the United States and the rest of the world. Fabric Genomics has proven its leadership in scaling complex interpretation services.
Read the full article: GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale //
Source: https://www.businesswire.com/news/home/20250416337382/en/GeneDx-to-Acquire-Fabric-Genomics-Enabling-Decentralized-AI-Powered-Testing-at-Global-Scale